| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |